Clover Health's Two Major Medicare Advantage Contracts Upgraded to 4.5 Stars by CMS for 2027
CLOV has more than doubled off its 52-week low of $1.58.
Summary
Clover Health announced that CMS has upgraded two of its Medicare Advantage contracts to 4.5-star ratings for the 2027 payment year. Its PPO contract H5141 improved from 3.5 to 4.5 stars, and the HMO contract H8010 increased from 4.0 to 4.5 stars. This positive development follows a recent 8-K filing on June 10th which reported a 4.5-star upgrade for the company's primary Medicare plan, and another 8-K on June 18th confirming upgrades for both PPO and HMO contracts. These 4.5-star ratings are critical as they directly increase the Quality Bonus Payments Clover Health will receive from CMS in 2027, significantly boosting future revenue and profitability. This expands the positive financial impact of high star ratings across a broader portion of its member base.
At the time of this announcement, CLOV was trading at $4.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $1.58 to $5.18. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.